Medical Research · MA
National Scleroderma Foundation Inc
National Scleroderma Foundation Inc reported paying Mary J Wheatley, Ceo, $253,525 in total compensation (FY 2024).
That places Mary J Wheatley at approximately the 54th percentile among 112 similarly sized medical research nonprofits (median $237,968).
$4,941,722Total revenue (FY 2024)
$253,525Total executive compensation
54thPercentile vs. peers
Setting executive pay for this board?
Generate a board-ready comparability report for National Scleroderma Foundation Inc — named comparables, percentiles, methodology, and the 26 CFR 53.4958-6 minutes language a board can use toward the rebuttable presumption.
Build the comparability report →Comparable medical research nonprofits
Compensation is normalized to MA cost of living (BEA Regional Price Parities); each organization's reported figure is on its linked 990.
| Organization | State | Revenue | Total comp |
|---|---|---|---|
| The Kidney Cancer Association | TX | $4,942,029 | $408,091 |
| American Society Of Regional | PA | $4,945,138 | $149,399 |
| Young Living Foundation | UT | $4,972,633 | $18,137 |
| Texas Health Research & Education Institute | TX | $4,905,286 | $592,434 |
| Papanicolaou Corps For Cancer Research | FL | $5,018,998 | $154,684 |
| Innovative Lifestyles Inc | MI | $5,029,226 | $285,685 |
| The Health Collaborative | OH | $5,036,985 | $170,275 |
| Pediatric Brain Tumor Foundation Of The United States Inc | NC | $5,039,446 | $389,963 |